Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in PCSA — Processa Pharmaceuticals, Inc.

CIK 1533421 NEW YORK, NY
Back to PCSA Full portfolio

Position in PCSA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,798
+$2,481 QoQ
Shares Held
2,499
+172.2% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 12 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. PCSA ranks #364 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in PCSA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,798 2,499
2026-03-31 $2,317 918
2025-12-31 $4,003 1,390
2025-09-30 $459 2,393
2025-06-30 $504 2,462
2025-03-31 $912 2,467
2024-12-31 $2,176 2,462
2024-09-30 $4,986 3,640
2024-06-30 $6,717 2,999
2024-03-31 $10,654 4,505
2023-12-31 $400 1,195
2023-09-30 $2,523 10,094
2023-06-30 $4,380 8,796
2023-03-31 $4 8,916
2022-12-31 $8,246 8,217
2022-09-30 $10,319 4,566
2022-06-30 $4,015 1,429
2022-03-31 $9,433 3,134
2021-12-31 $7,903 1,613
2021-03-31 $2,561 235
2020-12-31 $8,863 1,344